Ozempic and Wegovy are increasingly available in Australia and worldwide to treat type 2 diabetes and obesity.
The dramatic effects of these drugs, known as GLP-1s, on weight loss have sparked huge public interest in this new treatment option.
However, the risks and benefits are still being actively studied.
Details
Title
People on Ozempic may have fewer heart attacks, strokes and addictions – but more nausea, vomiting and stomach pain
Creators
Lauren Ball - The University of Queensland
Emily Burch - Southern Cross University
Publication Details
The Conversation
Publisher
The Conversation Media Group
Identifiers
991013252860902368
Academic Unit
Faculty of Health
Language
English
Resource Type
Magazine article
Browse and search our outputs
Browse and search our profiles
Browse by organisational units
Contact SCU Library Systems team
People on Ozempic may have fewer heart attacks, strokes and addictions – but more nausea, vomiting and stomach pain